• SENSEX
    NIFTY 50
Business

Strides Pharma rallies after Macquarie upgrades stock; expect EPS to triple in FY20

Updated : March 27, 2019 11:57 AM IST

Macquarie expects US margins to expand to 18 percent in FY20
Sees the company's US sales rising above $400 million in the next 3-4 years
Bulk of Strides’ US portfolio has been gaining market share
Strides Pharma rallies after Macquarie upgrades stock; expect EPS to triple in FY20

You May Also Like

Live TV
Advertisement